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Prior studies have shown that huma n skin possesses a 
cytochrome P-450-dependent microsomal enzyme that 
is capable of metabolizing drugs and polycyclic aromatic 
hydrocarbon (P AH) carcinogens. This study character-
ized benzo[a]pyrene (BP) metabolism in human epider-
mis of normal and psoriatic individuals. The basal level 
of the cytochrome P-450-depende nt microsomal enzyme 
aryl hydrocarbon hydroxylase (AHH) and epoxide hy-
drolase (EH) were measured in freshly keratomed epi-
dermis from 12 normal individuals and from uninvolved 
skin sites of 12 patients with psoriasis. The induction 
response of AHH following the in vitro addition of the 
P AH benz[a ]a nthracene (BA) was also assessed. The 
basal activity (mean ± SE) of AHH in normal epidermis 
was 62.1 ± 5.6 units (fmol 3-hydroxybenzo[a]pyrene, 
3-0H-BP/min/mg prote in) whereas the activity in un-
involved skin of psoriatic individuals was 62.9 ± 5 . 1 
units (NS), Epoxide hydrolase activity was 25.1 ± 1.1 
(pmol BP 4,5-diol/min/mg protein) units in normal epi-
dermis and 2 4 .8 ± 2.1 units in epidermis from patients 
with psoriasis (NS). Following addition of BA (100 11M), 
in vitro, AHH activity in normal epidermis increased by 
a mean value of 165% whereas activity in nonlesional 
epidermis of psoriatic individuals increased 320%. Ki-
netic studies in normal epidermis revealed that the AHH 
reaction was linear up to 60 min and to 50 Ilg protein, 
had a pH optimum of 7.4, and the K", for BP was 0.62 
11 M • High-performance liquid chromatography (HPLC) 
confirmed that the pattern of metabolism of BP was 
quite similar in epidermal microsomes prepared from 
normal and psoriatic individuals, insofar as the forma-
tion of diols, phenols, and qui nones was concerned. 
These studies indicate that human epidermis is capable 
of metabolizing BP and that there is no significant dif-
ference between normal individuals and patients with 
psoriasis insofar as basal AHH activity or total BP me-
tabolism is concerned. Furthermore, the epidermal en-
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zyme system in patients with psorias is has a greater 
responsiveness to environmental P AH than does that of 
normal individuals. 
The skin is t he major in terface between the body and its 
environment a nd is exposed to a variety of potentia lly tox ic 
chemica l a nd physical agents. Some of these agents, such as 
ult raviolet radiat. ion a nd selected PAH a re know n to be Onco-
gen ic for cuta neous t issue of huma ns and expe riment.a l animals 
[1 ,2 ]. In recent years it has become cleR r thRt the sk in is not 
simply a pass ive structural barrier impeding the penetra t ion of 
environmental agents, but rather t.his tissue po sesses enzymes 
capable of metabo li zing a variety of xenob iotics [3]. Th is met-
abolic capacity may be a major determinant of selected t.oxic 
responses such as chemica l carcinogenesis. Major ins ights int.o 
the mechanism of chemical carcinogenesis have developed from 
t he studies of t he Mille rs who suggested t hat oncogenic chem -
icals first. undergo metabolic a lteration by membrane-bound 
cytochrome P-450-dependent monooxygenases [4]. These en -
zymes convert a n inert procarcinogen int.o react.ive electrophiles 
t hat can bind cova lently to cellula r macromolecu les t hereby 
ini tiati ng t umorigenesis [4,5 ]. In t he case of PAH such as BP, 
3 successive enzymatic steps are required for t he ge neration of 
the ultimate oncogenic met.abolite [6]. These enzymatic steps 
include AHH, which forms an epoxide, followed by EH which 
cleaves t he epoxide in to dihydrodio ls. The dihydrodiol is t hen 
converted in to diol-epoxides by AHH. These have been iden-
tified in the skin of tumor-susceptible as well as tumor- res istan t 
mice fo ll owing topica l application of BP but are genera lly more 
inducible in t he former [7- 9J. AHH has been studied in organ 
cultures of human foreskin and its act.ivity was shown t.o be 
inducible following in vitro incubation wit h BA [10]. B ickers 
a nd Kappas [ll] subsequently showed that top ica l applica tion 
to huma n skin of therapeutic coal ta r so lutio n , a mixture which 
conta ins numerous PAH, caused substant ia l induct ion of cu-
taneous AHH activity. Human skin microsomes have been 
shown to possess EH activity [12J. 
Extensive studies in inbred mouse strains have shown t hat 
AHH activity and inducibili ty is a dominantly inherited t rait 
and t hat inbred stra ins with inducible enzy me activity a re more 
susceptible to t he induction of skin tumors following top ica l 
applicat.ion of PAH using standard ini t iation -promotion tec h-
niques [13]. These findings led to the hypothesis t hat AHH 
inducibili ty a nd suscept ibili ty to skin cancer by t he PAH may 
be related [14J. 
Recent ly, severa l studies have appea red in which epiderma l 
AHH activity in pat ien ts with the dermatologic disease known 
as psoriasis was compared to that of norma ls a nd found to be 
decreased [15,16J. On t he basis of t hese findin gs it was proposed 
t hat patients wi t h psoriasis have de fective AHH activity/ in -
ducibi lity a nd (a) that this defect could be somehow related to 
a fu nda menta l biochemical abberraLion of the skin in t his 
disease and (b) that patients with psorias is are resistant to sk in 
cancer from envi ronmenta l chem ica ls because of the deficient 
52 BICKERS ET AL 
act ivit.y of AHH. Epidemiologic studies do not s upport this 
concept. Stern et a l [17] have s h ow n that pati e n ts with psorias is 
who are intens ively t reated for many years with topically ap-
plied coa l products a nd ul t rav io let radiation are at substantially 
in c reased risk for t he development of skin ca ncer than are 
individual s who a re not so treated. Rawlins a nd Shuster [18 ] 
have reappraised th e ir earli e r o bse rvations a nd questioned the 
ve rac ity of their ea rlie r studies. In a recent publication , Finnen 
et a l were unanle to measure AHH activity in human epidermis 
obtai ned by t he s uction blister m ethod [19]. 
In th is study, we have measured AHH a nd EH activity in 
ke ratomed epidermis obta ined from uninvolved s kin of pso-
ri atic individuals and compa red it to epide rmis obtained from 
age- a nd sex-matched norm a l nonpso riatic controls. The in -
ducibility o f AHH was assessed by us in g a s hort-te rm organ 
culture i'ystem in whi c h ke rato m ed ep ide rmi s was incubated 
with a PAH. In add itio n , we a lso assessed t he patterns of BP 
meta bolis m by ski n microsomes of normal a nd psoriatic indi-
vidua ls. Our data indicate t.hat t here a re n o detectable differ-
e nces be tween n o rm a l a nd psoriatic individua ls in the basa l 
a n d induced leve ls of these e nzymes in huma n epidermis. 
Furthermore, e nhanced induc ibili ty of AHH by BA was ob-
se rved in psoriat ic epidermis a s compared to norma l epid e rmi s . 
MATERIALS AND METHODS 
h;pid(' rmal :)ompiinli 
Twelve pat i e nt ~ with plaque t.ype psor ias is involving at least 20% of 
their hody surface were studied at t.he Un ivers ity of Michigan Medical 
Center. Twelve norm a l individuals without a ny demonstrated derma-
to logic disease in whom no unusual environmental or occupational 
exposures cou ld he identified served as control s. None of the controls 
or the patients wit h pso ri as is had received a ny topical or systemic 
medica ti on for at leas t 14 days prior to obtaining ep idermis for study. 
E ve ry effort was made LO mat.c h the contro l popu lation with t he 
pso riat ic population insofar as age, sex, and smokin g history were 
concerned. A specia lly designed keralome was used 1.0 obta in epidermis 
as descrihed previously [20[. Sk in of the normal controls and visib ly 
uninvolved skin of the pat ient.s with psorias is were selected for study. 
The kera lomed epide rmal samples were obta ined from the lower trunk 
or t high. The sk in was first. cleansed thorough ly with a top ical anlisep-
tic a nd infill rated wit.h I % lidoca ine (Xyloca ine) wit.hout. epinephrine. 
Epidermal s trips -2.0 cm wide a nd -4 .5 cm long were ohta ined from 
each subject a nd immediately dropped into liquid nitroge n for later 
dete rmination of enzyme activit.y. For the AHH a nd EH induction 
st.udies the freshly keratomed epidermis was immediate ly div ided into 
2 segments and added to a ll o rga n culture system as described previ-
ously [I I [. Brie fl y, Eagle's minimum esse ntial medium containing 
Earle's balanced sa lt solut ion (Grand Isla nd Biological Co ., Grand 
Is la nd, New York), feta l hovi ne serum (Mi crobiologica l Assoc iates, 
Walke r~'Vi ll e, Maryland) , glu t.a mine, strep t.omycin , nystati n, and peni -
cillin G were Llsed. A solution of BA in acetone (0.05 m\) was dispersed 
in lO ml of the feta l bovine se rum which gave a fina l concentration of 
100 nM . The result.ing suspension W af; added to 190 ml of culture 
medium , shaken at 42 ' C for Hi h in the dark, and then passed through 
n 22-l'm pore s ize Millipore fi lter (Mi lli pore Co rp. , Bedford, Massac hu -
setts). Co nt rol medium was prepared identically except that acetone 
a lone was added . 
One segment. of tbe fresbly keratomed epidermis obtained from the 
co ntrols or from t.he uninvolved skin of psoriatic individual s was minced 
wit h surgica l sc i ~so rs and placed in control medium or in the BA-
trea ted medium and incubated in t he dark fo r 24 h at 3TC in a 
humidifi ed atmosphe re of !)% CO~ in air. At the conclusion of the 
incubat inn , the medium co ntain in g- the minced epide rm al segments 
was ce ntrifuged and the pellet washed 4 times with 0.1 M potassium 
phosphat.e bufTer, pH 7.4. The cpidermal pellet was ove rlaid with the 
sa me bufTer and frozen immediate ly in liquid N,. All samples were then 
shipped froze n in dry ice h.v air t.o Cleveland for the enzyme assays 
whl('h were a lwllYs per'formed within :l days of obtainin g the ti ssue. 
'l 'is .~UI' Preparation 
The epide rmis was thawed, washed once with 0.1 M phosphate bufTer 
pH 7.40, weighed. and homoge ni zed us ing a Polytron (Brinkma nn ) 
ti ssue homogcnizer. The ti ssue was mainta ined in a n ice-waler ha th t.o 
ohviate warming during process ing. This whole homogenate was poured 
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into the tube of a ground-glass conical tissue homogenizer filled with 
a ground-glass pes tle and was homogenized for 6 passes with a rotary 
drill press 13 1. The whole epidermal homogenate was then ce ntri{uged 
at 800 !J for 10 min; 800 g supernatants were ce ntrifuged at 9000 g, and 
the 9000 g supernata nt utili zed for assay of AHH and EH. Epidermal 
segments used for the study of enzyme induction were s imilarly ho-
mogen ized a nd 9000 g supernatant prepared . HPLC metabolism of BP 
was studied using human epidermal microsomes as t.he enzyme source. 
Epidermal microsomes were prepa red essentially as described earlier 
[.3 ] from pooled 9000 g supernatant from 6 norma l subjects a nd 6 
patients with psoriasis. 
E/l.zy me Assays 
AHH activit.y was dete rmined by a s\ightmodilication of the flu ori-
metric method described by Nebert [21J. Brie fl y a typical incubation 
mixture consisted of 10 mM potassium phospbate buffer (pH 7.4), 200 
nmol of NADPI-I , .300 nmol of MgC I" 12 ng of bovine serum albumin, 
and 100 1'1 of the enzyme source in a total volume of 0.2 m\. The 
reaction was initiated by adding 20 nmol BP in 10 1'1 of acetone a nd 
was incubated for 60 min at 37 ' C in a DubnofT metabolic shaker. The 
reaction was term inat.ed by the addition of 200 1'1 of co ld acetone and 
600 1'1 of hexane was then added . The quantitation of phenolic BP 
metabolit es was compa red to t.he flu orescence of 3-0H -B P Standard. 
EH act.ivit.y wit.h BP 4,5-oxide as substra te was measured as described 
previously [22 [. Protein was determined by the method of Lowry et a l 
[23 J. Details of these procedures were described ea rlie r [24 1. 
All dete rmina t ions were performed in trip licate and a zero t ime 
tissue blank was run for each assay. The values prese nted a re the mean 
obtained from .3 determinations On each sa mple. The enzyme assays 
were ca rried out completely blind. All samples were labeled on ly with 
code numbers, wh ich were assigned in Ann Arbor. At the co mpletion 
of a ll studies the code was broken and the va lues assigned to the 
appropri ate samples. These steps were taken to minimize possible bias. 
This was felt. to be particula rly important in these studies s ince the 
units of enzyme activity were quite low. The values obtained were then 
evaluat.ed for stat.istical significa nce us in g Student' s L-t.est. Compari son 
was made between normal a nd psor iatic individuals for basa l and 
inducible activity of AHH and EH. 
HPLC Analys is of BP Metabolism by Huma./l. Epidermal Microsomes 
HPLC a nalysis of BP meta bolism by human epidermal microsomes 
was studied by s light mod:lications of our procedure published on 
rodent skin 1251. The incubation mixture contai ned 2. 0 mg microsoma l 
protei n, 0.10 mmol phosp hate buffer (pH 7.4), 3 1'mol MgCI 2, and 1 mg 
NADPH in a final volume of 0.96 m\. The reaction was ini t iated by 
the addition of SO nmol [14C]BP in 40 1'1 methanol. The samples were 
incubated for 60 min in the dark at 37' C in a DubnofT metabolic shaker. 
The reaction was terminated by adding 1 ml of acet.one followed by 2 
ml of ethyl acetate. The mixt.ure was vort.exed for I min to extract anv 
unreacted BP as well as the metabolites into t he organic phase. Th~ 
orga nic and aqueous laye rs were separated by centrifugation at 1.500 
rpm for 5 min. The radioact.ivity in t he aqueous phase was less than 
0.5% of the to tal radioact ivity and was proportional to the total BP 
metabolized. The organ ic phase was then dehydrated over a nhydrous 
MgS0 4 , dried under a stream of N" and dissolved in 501' 1 of metha nol 
for HPLC analysis. 
A Wate rs Associa tes model 440 liquid chromatograph, filted with 
Waters Associate uBondapack C I8 column (4 .6 x 25 mm) was used for 
analys is of the radiolabeled BP metabolite mi xtures. Identification of 
the metaboli tes was based on reference standa rd. The column was 
eluted at a mbient temperature with a 30-min linear gradient of meth-
anol:water:tetrahydroruran (THF) (70:27:3, v/v) to methanol at a sol-
vent /low rate of 0.5 mf / min. The elual.es were monitored at 254 nm 
frac tions of approximal.ely 0.2 ml were collected dropwise, and Lh~ 
radioactivit.y of eac h fraction determined on a Packard TriCa rb 460 
CD liquid scintillat.ion spectrometer. The counting efficiencies of t he 
ea rly e luted fradions, containing a higher percentage of water, were 
about 2% lowe r than those of t. he fractions e luted with methanol. 
Chemical.\· 
[I .IC]BP (sp act 2S.5 mCi/ mmol) was purchased from New E ngland 
Nuclea r (Bos ton, Massachusetts) a nd was purified by a s ilica ge l (Bio-
Sil A, 100-200 mesh, BioRad Laborat.ories) column with hexane as the 
elul.ing solvent and subseque ntly by reverse phase H PLC using a 
DuPont Zorbax OBS column eluted with methanol:water (9:1, v/v) . 
[1 4C] BP was dilul.ed with unlabeled 13P (S igma Chemica l Co., Sl. Lou is, 
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FI G 2. Human epidermal AHH as a function of BP concentrat ions. 
Enzyme activity was measu red afte r 60 min as described in Materials 
and M ethods. The co nce ntra tion of BP was varied as indicated in the 
figure. A Lineweaver-Burk representation of the data for determination 
of an approximate 1<,.. value is provided in t he inset. 
Missouri) to a ~p act of 22.5 mCi/ mm ol. ["HJBP 4,5 ox ide (sp act 282.5 
mCi/ mmoi: radiochemica l purity greate r t.han 99%) and chromato-
graphica lly pure unl abeled BP 4,5 -oxide, BP 4,5-dihydrodiol, and BP 
metaboli te reference standards were obtained from the Chemical Re-
pository Unit of NHtional Ca nce r Inst.itut.e, Bethesda, Maryland. All 
solvents and chemica ls used were of t he highest grade commercially 
available. 
RESULTS 
Characteri:;tics of AHH in Human Epidermi:; 
S ince a modification of t he standard AHH assay was devel-
o ped for dete rmination of enzyme activity in fres hly keratomed 
human epide rmi s, ini tia l experiments were performed to define 
the optimal cond itions for the procedure . Fig 1 s hows t hat t he 
rate o f the reaction in 9000 g supe rnata nt o f human epidermis 
was linea r up to a protein co ncentration of 50 Mg, lip to an 
incubation t ime of 60 min, and t.hat optimfl l cata lytic activity 
occurred at a pH o f 7.4. These e nzy me characteristics are 
s imilar to those in the ep ide rmi s of neonatal rodents which 
were publi shed previously [3J. The apparent J(,,, value for BP 
in human ep ide rmi s was 0 .62 x 10-" M. The V",,,, for huma n 
epidermal AHH was 70 fmol/m in / mg protein (Fig 2). 
Comparative A HH and EH Activity in No rmal and Psoriatic 
S ubject:; 
T he data for AHH activ ity in ke ra to med epide rmis obtained 
fro m indi vidua l no rmal subjects and from individua l psoriat.ic 
16 
c. 
/\ 
6 5 7 75 8 8 .5 
pH 
FIr. 1. Opt.imal condit.ions for assav-
ing AHH ac tivity in human epiderm is. 
The assay co ndi t ions of AHH activity 
are as described in t.he text with t.he 
exception of (a) protein concentrat ion , 
(b) t ime of incubat io n , and (c) pH of t he 
incubation mixt.ures which were va ried 
as indicat ed. 
TABLE I. Comparative activity of ary l hydrocarbon hydroxy lase in. 
cpidermis from n.ormal subjects and from paticnts with psoriasis 
NornUJ I sulljeds AHH" Psoricltic AHI-I" pat ients. 
A 80 A 56 
B 85 B 67 
C 83 C 107 
0 66 0 52 
E 44 E 52 
F 50 F 37 
G 83 G 67 
H 53 H 80 
I 24 I 63 
J 68 J 49 
K 64 J( 58 
L 45 L 67 
Mea n ± SE 62.1 ± 5.6 62.9 ± 5. 1 
" Aryl hyd roca rbon hydroxlase, fmol 3-0H-BP/ min/mg prot.ein. 
Keratomed ep idermis was obta ined '·rom normal volun teers and from 
visibly uninvolved skin of pat.ients wit.h psorias is and assayed for AHH 
activit.y as described in Materials and Methods. 
patients are presented in Table I. There was a wide ra nge of 
va lues in both normal and psoriatic individuals, though, as can 
be seen, they, for the most part, could be grouped into similar 
patt.e rns. These differences in activity were consistent regard -
less o f whether t he resul ts were calculated on the basis of units 
of enzyme activity per mg protein or wet weight . The mean 
AHH activity in epidermis obta ined from t he normal popula-
tion was 62.1 ± 5.6, whereas t he mean activity in non involved 
epidermis obtained from the psoriatic individuals was 62.9 ± 
fl. l (Tab le I) . There is no statistica lly significant difference 
between these two populations insofar as basal ep iderma l AHH 
activit y is concerned. 
In f~rther studies we attempted to dete rmine the extent. to 
which huma n epidermal AHH was inducible in vitro by BA. A 
show n in T able II , AHH activity in both normal and psoriatic 
epidermi s was inducible by BA. AHH activity in the epidermis 
obtained from the norma l con trols increased by a mean value 
of 165 ± 26% whereas the ep idermis obtained from non involved 
skin of psoriatic individua ls increased by a mean of 320 ± 29%. 
Thus t he respons ive ness of epidermal AHH to BA added in 
vitro was a pproximately 2-fold greater in patients with psoriasis 
as compa red to no rmal individuals. 
EH act ivity was detectab le in epiderm is obtained from both 
t he normal a nd the psoriatic populations. The mean ± SE 
activ iti es in eac h were 25.1 ± 1.1 a nd 24.8 ± 2.1, respectively 
(Table III ). There is no statistica lly signiiicant difference be-
t ween the two . 
HPLC Profile of BP M etabolism. ill Human Epidermis 
As s hown in Table IV , HPLC ana lysis of human epiderma l 
mic rosomal metabolism of BP revea led that diols, quinone, 
54 BICKERS ET AL 
TABLE II. Comparative inducibility of epidermal microsomal A H H by 
BA in normal su.bje~ts and patient .. , with psoriasis 
AHH" 
- 13A +BA % I nduction 
Normal subjects 
A 83 280 2:37 
B 50 165 220 
C 24 62 158 
D 53 9 1 72 
E 78 169 117 
F' 44 132 200 
G 71 114 61 
H 59 208 252 
Mean ± SE 57.8 ± 6.9 152.6 ± 24.5 165 ± 26 
Pso riatic pat ients 
A 20 96 220 
B .'):) 196 270 
C G7 :rll :364 
D 55 240 336 
E 5 1 26(; 422 
F 49 20 1 310 
Mean ± SE 49.2 ± 6.0 218.3 ± 30.0 :120 ± 29 
U fmol s :l-O H-BP/min/ mg protein . BA = benz[aj anlhrace ne; AHH 
= aryl hydrocarbon hydrox lase. 
F reshly keratomed epidermi s was immedi ate ly spli t into 2 segments 
and incubated fo r 24 h in ti ssue cu ltu re medium co ntaini ng BA. 
Cont rols were incuhated without the hydroca rbon. AHH activity was 
then determi ned as descr ibed in Materia.ls and Methods. 
TABLE 111. Microsomal epuxide hydrolase activity ill. epiderm.is of 
normal i"div idlla~, and in patients with psoriasis 
No rmal subject, EH" Psoriatic EH patients 
-------
A 22.2 A 30.:3 
B 27.5 B 28.8 
C 26.2 C 15.4 
0 24.0 0 18.0 
E 19.0 E :\6.8 
F 28.9 F 38.3 
G 22 .2 G 22 .4 
H 23.8 H 23.7 
I 26.4 I 18.4 
J 2'\'4 ,J 22.6 
K 33.9 K 19.7 
L 22.4 L 23.3 
Mean ± SE 25.1 ± 1.1 24.8 ± 2.1 
U Epoxide hydrolase, pmol BP 4.5-diol/min / mg protein . 
For other det a ils see Table I. 
and phenolic metabolites of t he carcinogen were formed by 
both normal and psoriatic individua ls. Total metaboli sm a nd 
t he ove rall pattern of metabo li te formation were s imilar in each 
popu lation. BP trans-7,8-diol is the precurso r of t he ul t imate 
ca rcinogen of BP [6,8). T he formation of t his particula r metab-
olite by human epidermal microsomes was only s li ghtly higher 
in pso riatic patients as compared to norma l subjects. T hese 
data provide further confirmation of t he similari ty between 
normals and psoriatic individuals insofa r as ep idermal micro-
somal carcinogen metabol ism is conce rned. 
DISCUSSION 
The etio logy of psorias is has been increasingly studied in 
recent years and in pa rti cu lar t he possibili ty that a spec ific 
enzyme defi ciency is responsibl e for the disease has in t ri gued 
some individuals. I n prior studi es Shuster a nd his associates 
~iUggested t hat patients wit h psoriasis had a n intrins ic defect 
in the basa l act ivity and the inducibility of t he ca rcinogen -
metabolizing enzyme, AHH, in t he epidermis [15,16) and that 
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TABLE IV. Pa.tterns of metabolism of /' ·'Cjben.zo /a}pyrene by 
epidermal microsomes from normal individual., a.n.d from patl:ent:; with 
psoriasis 
Mcwbolil cs 
trans-9,10-dio l 
tralls-4 ,5-diol 
trans-7,8-dio l 
1,6-quinone 
3,6-quinone 
6, 12-quinone 
9-0H-B P 
3-0H-8P 
T otal phenols 
Total metabolites 
BP mclaholi"n 
(1'0101 product /50 min/ mg mic rosomal proLei n) 
No rmal subjects 
4. 1 
11.8 
3.2 
65.4 
45.4 
68.G 
6.2 
10.7 
16.9 
21;".4 
Psoriatic patients 
7.2 
13.6 
4.8 
60.8 
29.9 
70.:3 
5.8 
lOA 
16.2 
202.8 
Ski n 9000 g supernatants from 6 subjects were pooled a nd mic ro-
somes prepared. Incubation mi xtu re in I ml tota l volume cont.a ined 2.0 
mg microsoma l protein . Incubations we re carried out at 37°C for 60 
min and the metabolites extracted as described in Matert:a.ls and M eth -
ods. 
t his defect was detectable in other t issues as we ll [26J. From 
t hese observations t hey proposed t hat defective AHH activity 
might be a ma rker for this disease [27]. Furthermore, on t he 
basis of t heir cli nical experience t hese workers suggested t hat 
the incidence of sk in cance r in patients with pso ri as is was low 
and t hat t his was d irectly related to t heir observation t hat 
psoriatic ep idermis had a reduced capac ity t.o metabolize car-
cinogenic PAH [281-
The question of unique susceptibility of se lected human 
populations to ca ncer as a resul t of exposure to environmental 
carc inogens was first ra ised in 1775 by t he classical studi es of 
a London surgeo n, Perc iva l Pott (29). H e po inted out his 
experience wit h sc rotal cancer in chimney sweeps a nd made 
the seminal observation t hat t his popu lation of workers ap-
pea red to be uniquely susceptible to develop ing t hi s spec ific 
type of neoplasm. Fron. his observations, Pott p roposed t hat 
huma n sk in cancer could be caused by exposure to environ-
mental age nts, a concepl that remains valid un t il t he present 
day. The major environme nta l oncogens for huma n skin that 
have been identified are sola r ult rav iolet radiation a nd se lected 
chem ica ls, among t hem the PAH [30,31 J. The PAH are gener-
ated whenever carbonaceous material such as fossi l fu els are 
incomp lete ly combusted. Both ul t rav iolet radiation a nd crude 
coal tar, a substance produced by destructive distillation of coal 
which is rich in PAH, are wide ly used in t he management of 
psorias is [32], a modality kn own as t he Goec kerma n regimen 
named for t he individua l who first desc ribed it [33]. 
In recent yea rs much important new knowledge regarding 
the mechan ism of chemical carcinogenesis has deve loped 
[5,6J- It is now well estab lis hed tha t inducible membrane-bound 
enzymes such as AHH, present in many types of cells, including 
the skin [3], can convert selected biologica lly inert chemicals 
into highly reactive electrophilic metabo lites which can bind to 
macro molecules t hereby initiating t umor fo rmation [4- 6) . 
Studies in human populations have attempted to dete rmine 
whether AHH inducibili ty or responsiveness can be co rrelated 
with suscept ibili ty to cance r. Kell erma n et al measured AHH 
inducibili ty in mitogen-stimulated lymphocytes obtained from 
patients with lung cancer and compa red it to ce lls obta ined 
from patients wi t h other forms of cance r and from normal 
con t rols [34]- Their resul ts indicated a t rimoda l distribu t ion of 
AHH inducibility (low, intermediate, and high) in t he normal 
population and showed that a disproport ionate number of 
patients with lung cancer had inte rmediate or high inducibility 
of AHH in t heir lymp hocytes. Subsequently, considerable con-
t rove rsy developed regardin g the relationsh ip of the inducibility 
of AHH in human lymphocytes to human cancer because it 
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was n ot. possible t.o co nfirm these findings [35-37]. Further-
more, it. became clear that the lack of rep roduc ibili ty of t he 
assay procedure in mit.oge n -stimu lat.ed ly mphocytes was a m a-
jor source of difficu lt y 138], For example t.here is some evidence 
to s u ggest that there is seaso na l va ri at.ion in AHH activity in 
hum a n Iy mphocyt.es with lO -fo ld hi ghe r activity in selected 
individuals during late summer a nd ear ly fall [39] . Others have 
s hown that th e respon s iveness of ly mphocytes to mitogens is 
inhibited eve n in ce rtain pat.i e nts very ea rly with (Stage 1) lung 
ca n ce r [40]. In such individual s diminished AHH inducibility 
could resu lt. from a chan ge in t.he responsiveness of t he ce ll 
being studi ed rat he r t.han as a n inhe rited tra it. 
AHH activi ty a nd inducihility in psoriatic s kin was studied 
by C h apman et a l who obta ined epide rmis fro m involved a nd 
uninvolved s kin o f patients with psoriasis a nd from n o rmal 
contro ls using a s uctio n bli ste r t.echnique. The suction bliste rs 
we re divided in to t.wo pa rts, o ne of which was inc ubated with 
BA for 18 h , a nd AHH activity measured [15 ]. From the ir data 
it was concluded t.hat. in the epide rmi s of patients w ith p so rias is 
there is defective AH H activity such t hat. the basa l leve l of the 
e n zy m e a nd its induction response (,0 a n induce r are both 
decreased, and it was suggested t hat defic ie n t AHH activity 
could be a primary genetic abnorma lity in psoriasis. 
The dat.a prese n t.ed here do not co nfirm the results o f C hap-
man et a l [] .'1,26,27 J a nd Shuster et. al [16 ,28J regarding differ-
ences between normal and psoriat ic individuals in t he basal 
a nd induc ibl e levels of epide rmal AHH. During the course of 
our studies Rawlins a nd Shuster doubted t he veracity of their 
earli er obse rvatio n 118 ]. T hese invest iga to rs lat.er s ugge. ted 
that AHH act.ivity in s uctio n b li ste rs of huma n epide rmi s is 
not mea urab le [19J. Our data do indicate that ke ratomed 
human ep idermis possesses m easura ble levels o f AHH and EH 
activ ity and t hat there a re no stat. istically s ignificant differ-
e nces betwee n t.he basa l leve ls o f ep iderma l AHH and EH 
activi t ies in n o rmal and pso riat ic individuals. However AHH 
in epidermis obt.a ined from v is ibly uninvo lved s kin of pso riati c 
individuals is twice as respo n s ive to BA as is t he enzyme in 
normal epide rmi s . Our data also ver ify t hat t he microso m a l 
cytochrome P-450 is present and induc ibl e in huma n ep ide rmi s. 
Furthermore we have s how n that. human epide rmis is capable 
of metaboli zing BP in to a large numbe r of derivatives. This 
suggests that topicaily appli ed d ru gs are like ly to be substrates 
for microsom a lmonooxygenases in the e pide rmi s. This t.ype o f 
catalytic activity could be a n importa nt det.e rminant of drug 
efficacy in hum a n s kin. 
It is of interest that recent. studies in cultured ly mphocytes 
of p soriatic patie nt.s fou nd t hat there was no s ignifica n t differ-
e nce in the m ea n basa l and induced AHH activities between 
t h ese ce ll s a nd ce ll s obtained from no rm a l individua ls r 41,42 ] . 
There is a lso ep ide mi o logic evidence to s uggest that psoriatic 
individuals a re no t resistant to the development of s kin cancer 
[17 ]. 
In summary, there appear to be no differe nces in the patterns 
of ep iderma l ca rc inogen metaboli s m between n o rma l indiv idu -
a ls and pat ie nt.s wi t h psori as is. Furt'he r st.udies are needed to 
ident.ifY the s pec ific enzymatic a bno rmaliti es that playa role 
in t h e pathogenesis of thi s d isease. 
We t ha nk Ms. Bet ty Olso n and Mrs. Sa ndra Evans for prepa ration 
of the manuscript. 
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